A mouse model of non-necrotic vascular deficiency in the adult heart was studied using cine-magnetic resonance imaging (MRI) and other techniques. The mice lacked cardiomyocyte-derived vascular endothelial growth factor (VEGF) following a targeted knockout in the ventricular cardiomyocytes. Quantitative endothelial labeling showed that the capillary density was significantly reduced in the hearts of knockout mice. Gene expression patterns suggested that they were hypoxic. Semiautomated MR image analysis was employed to obtain both global and regional measurements of left ventricular function at 10 or more time points through the cardiac cycle. MRI measurements showed a marked reduction in ejection fraction both at rest and under low-and high-dose dobutamine stress. Regional wall thickness, thickening, and displacement were all attenuated in the knockout mice. A prolonged high-dose dobutamine challenge was monitored by MRI. A maximal response was sustained for 90 minutes, suggesting that it did not depend on endogenous glycogen stores. J. Index terms: VEGF; cine; dobutamine; mouse; heart THE RECENT PROLIFERATION of murine models of human heart disease has been remarkable (1) and is likely to continue. Although MRI has been elegantly applied by several groups to studies of the mouse heart (e.g., Refs. 2-5), it remains concentrated in relatively few centers. Cardiac MRI of the mouse, unlike of the rat (6), is not widespread in the pharmaceutical research setting, but that seems likely to change as the advantages of murine models increasingly outweigh their disadvantages. There are important biological differences between the hearts of different mammals, such as in calcium handling (7) and vascular anatomy (8), yet many of the perceived disadvantages of using mice as opposed to larger animal species are essentially technical in nature. This has spurred great efforts in adapting radiological, surgical, and physiological techniques to the temporal and spatial scale of the mouse heart (9,10).This paper describes MRI of the left ventricle (LV) under resting and stressed conditions in a mouse model of a non-necrotic vascular deficiency in the adult heart. This model may be of some value in designing and evaluating angiogenic therapies (11), and in understanding the pathophysiology of chronic ischemic conditions associated with coronary artery disease (12). The generation and preliminary phenotypic characterization of this mouse model has recently been described (13). Briefly, the Cre/lox system (14) was employed to generate a targeted knockout of vascular endothelial growth factor A (VEGF A) specific to the ventricular cardiomyocytes. VEGF A is a potent cytokine and mitogen involved in the formation and maintenance of blood vessels (15). Attempts to generate VEGF A knockouts by the more common germ-line strategies were confounded by the highly unusual embryonic lethality seen in VEGF A heterozygotes (16).The effect of the gene knockout was monitored directly (changes in VEGF A mRNA) and indirectly. Anticipating microvasc...